Work

Analysis of Fcγ Receptor IIA & IIIA Polymorphisms: Correlation with Outcome in Trastuzumab-Treated HER2/Neu Amplified Early and Metastatic Breast Cancer Patients.

Year: 2009

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/0008-5472.sabcs-09-64

Authors: S. Hurvitz, D. Betting, H. Stern, E. Quinaux, J. Stinson, S. Seshagiri, Y. Zhao, M. Buyse, J. Mackey, N. Robert, V. Valero, J. Crown, A. Driga, V. Bee, D. Slamon, J. Timmerman

Institutions: University of California, Los Angeles, St. James's Hospital, International Drug Development Institute (Belgium), Cross Cancer Institute, The University of Texas MD Anderson Cancer Center, Cancer Trials Ireland

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1969826104

Cites:

Cited by: 8

Related to: 10